Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


New Safety Framework Mixes Current Efforts, New Investments At US FDA

Executive Summary

In a new "action plan," FDA is stitching together a plethora of ongoing and proposed initiatives to help spur product safety and quality efforts through increased regulatory authority and more incentives for device-makers.


Related Content

Lack Of Funding Stalls Major US FDA Cybersecurity Initiative
‘Disease Doesn’t Respect Silos’: Sharpless Sets Flexibility As Priority
FDA Marches Forward With 'STeP' Program To Aid Development Of Significantly Safer Medtech Products
Proposed FDA Guidance Would Provide Alternate Route For 510(k) Applications
5 Ideas To Improve Device Cybersecurity
Digital Health, Cybersecurity Would See Significant Chunk Of FDA Device-Funding Boost
Stacking Bricks: FDA Unveils Structure For New Office Of Product Evaluation And Quality, Touts Benefits Of OPEQ
NEST Coordinating Center At Year One: Device Data-Sharing Network In Its Sights
9 Device-Makers Wanted For US FDA Pilot Program To Measure Quality System Maturity
Quality On The Brain: FDA Maturity Pilot Aims To Shift Industry's Compliance Mentality To A 'Quality Mindset'





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts